Compassionate Use for Subcutaneous (SC) Belimumab
Condition(s):Systemic Lupus ErythematosusLast Updated:February 28, 2018No longer available
Hide Studies Not Open or Pending
Condition(s):Systemic Lupus ErythematosusLast Updated:February 28, 2018No longer available
Condition(s):FLT3-ITD Mutation; FLT3/TKD Mutation; PDGFR-Alpha D842V; PDGFRA Gene AmplificationLast Updated:May 22, 2020Available
Condition(s):MyelofibrosisLast Updated:September 18, 2020Available
Condition(s):Aortic Arch AneurysmLast Updated:January 5, 2024Completed
Condition(s):Human Immunodeficiency Virus Type 1Last Updated:May 4, 2016Withdrawn
Condition(s):HIV InfectionsLast Updated:November 14, 2023Available
Condition(s):Solid TumoursLast Updated:April 13, 2020No longer available
Condition(s):MET Alterations; Non Small Cell Lung Cancer; METex14 MutationsLast Updated:January 6, 2023Completed
Condition(s):SarcomaLast Updated:October 22, 2015No longer available
Condition(s):Alzheimer DiseaseLast Updated:July 25, 2023Available
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.